Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

292
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
292
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

258
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
258
Survival Tree01:19

Survival Tree

164
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
164
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

129
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
129
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

318
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
318
Cluster Sampling Method01:20

Cluster Sampling Method

12.8K
Appropriate sampling methods ensure that samples are drawn without bias and accurately represent the population. Because measuring the entire population in a study is not practical, researchers use samples to represent the population of interest.
To choose a cluster sample, divide the population into clusters (groups) and then randomly select some of the clusters. All the members from these clusters are in the cluster sample. For example, if you randomly sample four departments from your...
12.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016-2022).

The Lancet regional health. Southeast Asia·2026
Same author

A joint latent-class Bayesian model with application to ALL maintenance studies.

Journal of applied statistics·2026
Same author

PREPARE ALL: An Artificial Intelligence Tool for Predicting Relapse in Children With Acute Lymphoblastic Leukemia.

JCO clinical cancer informatics·2026
Same author

Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from India.

The Lancet regional health. Southeast Asia·2025
Same author

Distance-decay equations of antibiotic resistance genes across freshwater reservoirs.

Water research·2024
Same author

A Bayesian quantile joint modeling of multivariate longitudinal and time-to-event data.

Lifetime data analysis·2024

Related Experiment Video

Updated: Sep 16, 2025

Using Cholesky Decomposition to Explore Individual Differences in Longitudinal Relations between Reading Skills
06:52

Using Cholesky Decomposition to Explore Individual Differences in Longitudinal Relations between Reading Skills

Published on: September 17, 2019

6.4K

Simultaneous clustering and joint modeling of multivariate binary longitudinal and time-to-event data.

Srijan Chattopadhyay1, Sevantee Basu1, Swapnaneel Bhattacharyya1

  • 1Indian Statistical Institute, 203 B.T. Road, Kolkata, India.

Lifetime Data Analysis
|July 11, 2025
PubMed
Summary

This study introduces a novel Bayesian approach to cluster heterogeneous patient populations in joint modeling of longitudinal and time-to-event data. The method effectively identifies distinct patient subgroups, improving statistical inference for cancer relapse prediction.

Keywords:
Acute lymphocytic leukemia (ALL)Bayesian consensus clusteringBinary longitudinal outcomesJoint modelingMCMC

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K

Related Experiment Videos

Last Updated: Sep 16, 2025

Using Cholesky Decomposition to Explore Individual Differences in Longitudinal Relations between Reading Skills
06:52

Using Cholesky Decomposition to Explore Individual Differences in Longitudinal Relations between Reading Skills

Published on: September 17, 2019

6.4K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K

Area of Science:

  • Biostatistics
  • Medical Statistics
  • Clinical Trial Analysis

Background:

  • Joint modeling of longitudinal and time-to-event data is crucial in medical research.
  • Heterogeneous populations necessitate clustering for robust statistical inference.
  • Existing methods may not adequately address complex patient subgroupings.

Purpose of the Study:

  • To develop a Bayesian joint modeling framework incorporating clustering for multivariate binary longitudinal outcomes and time-to-event data.
  • To analyze a clinical trial dataset from cancer patients to identify distinct subgroups.
  • To assess the impact of identified clusters on relapse prediction.

Main Methods:

  • Utilized Bayesian data-augmentation for latent continuous outcomes from multivariate binary longitudinal data.
  • Employed Bayesian consensus clustering to identify patient subgroups.
  • Performed cluster-specific joint analysis using generalized linear mixed models and proportional hazards models.
  • Applied the method to a cancer clinical trial dataset with biomarker measurements and relapse times.

Main Results:

  • Identified three distinct latent patient clusters.
  • Demonstrated substantial differences in covariate effects and median non-relapse probabilities across clusters.
  • Simulation studies confirmed the effectiveness of the simultaneous clustering and joint modeling approach.

Conclusions:

  • The proposed Bayesian framework effectively clusters heterogeneous patient populations within joint modeling.
  • This approach enhances statistical inference and provides more precise predictions for time-to-event outcomes.
  • The findings have significant implications for personalized medicine and clinical trial design in oncology.